Copyright
©The Author(s) 2021.
World J Meta-Anal. Apr 28, 2021; 9(2): 139-152
Published online Apr 28, 2021. doi: 10.13105/wjma.v9.i2.139
Published online Apr 28, 2021. doi: 10.13105/wjma.v9.i2.139
Hepatitis | Serological testing | Molecular testing (via PCR), quantitative |
A | Anti-HAV IgM (acute); Anti-HAV IgG (previous infection, vaccination); Note incubation period of 28 d[92] | HAV RNA |
B | Anti-HBc (contact with HBV infection); HBsAg (current infection) appears 1-3 wk post exposure, duration > 24 wk denotes chronicity; Anti-HBS (vaccination, cleared HBV infection); HBeAg (high replication phase (> 10000 IU/mL); Anti-HBe (low replication phase (< 10000 IU/mL); Note incubation 90 d (ranges 45-160 d); Window period 1: first about 8 d of infection; Window period 2: clearance of HBsAg during this period Anti-HBc IgM is detectable[93] | HBV DNA |
C | Anti-HCV: Note incubation 6-7 wk (ranges 2 wk to 6 mo)[93] | HCV RNA |
D | Anti- HDV IgG | HDV RNA |
E | Anti-HEV IgM and IgG and IgA | HEV RNA |
- Citation: Fagan O, Armstrong P, Merwe KVD, Crosnoi D, Steele C, Sopena-Falco J, Parihar V. Viral hepatitis: A brief introduction, review of management, advances and challenges. World J Meta-Anal 2021; 9(2): 139-152
- URL: https://www.wjgnet.com/2308-3840/full/v9/i2/139.htm
- DOI: https://dx.doi.org/10.13105/wjma.v9.i2.139